HOME > PUBLICATIONS > Arthritis & Rheumatism > 1998 > SUBJECT > Subject Index - P

Subject Index - P

Back to Subject Index | Return to Arthritis & Rheumatism Table of Contents Page

  • P-31 magnetic resonance spectroscopy (MRS), in fibromyalgia, 406
  • PA inhibitor (PAI-1), in OA, 891
  • Paclitaxel, inhibition of matrix metalloproteinase expression, 869
  • Paget's disease, bisphosphonate treatment of, 354
  • Pain
    • cyclosporine-associated bone, 565
    • low back, prevalence in United States, 778
    • opioids for, in rheumatic diseases, 1603
    • in RA, long-term risk for depression, fatigue, disability and, 1851
    • syndrome, chronic, and neck injury, 758
  • Pancytopenia, drug-induced, in juvenile HLA-B27-associated spondylarthritis, 1899, 1900
  • Pannus cells, and monoclonal expansion of synoviocytes in RA, 1979
  • Papulonecrotic tuberculid, and Poncet's disease in HIV, 1884
  • Paraneoplastic syndrome, cutaneous vasculitis in adults as, 1133
  • Paraparesis, in SSc, 1321
  • Parathyroid hormone, human, in OA, 891
  • Parathyroid hormone-related protein (PTHrP), articular expression, 2152
  • Pauciarticular juvenile rheumatoid arthritis, intraarticular corticosteroid therapy in, 1210
  • Peptides
    • C-telopeptide breakdown products (CTX), type I collagen, in Paget's disease, 354
    • N-telopeptide breakdown products (NTX), type I collagen, in Paget's disease, 354
    • N-terminal, stimulation of proteoglycan biosynthesis in human articular cartilage, 157
    • pituitary adenyl cyclase-activating polypeptide, in fibromyalgic muscle tissue, 1689
    • purity of synthetic ribosomal, in enzyme-linked immunoabsorbent assay, 1137
    • T cell receptor peptide vaccine in RA, 1919
  • Percutaneous vertebroplasty, in the treatment of steroid-induced osteoporotic compression fractures, 171
  • Perforin, and CD4 subsets in rheumatoid synovitis, 2108
  • Pericarditis, camptodactyly-arthropathy-coxa vara-, 730
  • Periodontal health, in RA, 2081
  • Peripheral blood stem cell transplantation (PBSCT), remission of SLE and, 2271
  • Peripheral blood T lymphocytes (PBTL), human
    • αEβ7 expression and adhesion in, in SLE, 1456
    • matrix metalloproteinase 1 and prostaglandin production in synoviocytes and fibroblasts and, 1748
    • vascular cell adhesion molecule 1/very late activation antigen-mediated cell adhesion and NSAIDs, 1677
  • Peripheral nervous system, nonsystemic necrotizing vasculitis of, 1324
  • Pertussis toxin, and T cell adhesion inhibition in rheumatoid synovitis, 1365
  • Phagocytosis, impaired, apoptosis in SLE, 1241
  • Phalangeal osseous sarcoidosis, 176
  • Phosphatidylserine (PS), and anti-endothelial cell autoantibodies, 1738
  • Pima Indians
    • OA in, 361
    • RA in, 1464
  • Piroxicam, vascular cell adhesion molecule 1/very late activation antigen-mediated lymphocyte cell adhesion and, 1677
  • Pituitary adenyl cyclase-activating polypeptide, in fibromyalgic muscle tissue, 1689
  • Plasmapheresis-treated SLE, severe infections in, 414
  • Platelet endothelial cell adhesion molecule 1 (PECAM-1), in polyarteritis nodosa, 435
  • Platelet-derived growth factor (PDGF)
    • intimal hyperplasia and ischemia in giant cell (temporal) arteritis, 623
    • monoclonal expansion of synoviocytes in RA and, 1979
  • Pneumococcal vaccine, and antigen-specific antibody responses after immunizations in SLE, 1828
  • Pneumonitis, MTX-associated, 1327
  • Poly(ADP-ribose) polymerase (PARP), autoantibodies to, 918
  • Polyangiitis, treatment of, 2100
  • Polyarteritis
    • adjuvant-induced, in rats, and DMH-11C, 163
    • Th1 cytokines in aggrecan-induced, 1007
    • type II collagen versus proteoglycan-induced, 1007
  • Polyarteritis nodosa (PAN)
    • endothelial cell adhesion molecule expression in, 435
    • segmental mediolytic arteriopathy mimicking, 935
    • treatment of, 2100
  • Polymerase chain reaction (PCR)
    • bacteria in joints identified by, 535, 845, 2276, 2278
    • cathepsins and MMPs identified by, 1378
    • Chlamydia identified by, 845, 1894
    • competitive, 48
  • Polymethylmethacrylate (PMMA), in the treatment of steroid-induced osteoporotic compression fractures, 171
  • Polymorphisms
    • in collagen I α1 associated with osteoporosis, 187
    • hip OA, and vitamin D receptor, COL1A1, and COL2A1 in postmenopausal women, 1946
    • in SLE, FcγRIIa, 421, 1181
    • in SLE, FcγRIIa-158V/F, 1813
    • SLE associated with promoter, of mannose-binding lectin gene, 1663
    • tumor necrosis factor α, and ankylosing spondylitis, 1489
  • Polymyalgia rheumatica (PMR)
    • cardiovascular risk factors and, 1960
    • distal musculoskeletal manifestations in, 1221
    • prevalence in United States, 778
  • Polysulfone dialyzers, colchicine clearance by high-flux, 749
  • Poncet's disease, and papulonecrotic tuberculid in HIV, 1884
  • Population-based studies, and spondylarthropathies, 58
  • Porphyria, acute intermittent, diagnosis uncertainty in, 188, 189
  • Prednisolone, in early RA, 1203, 1709, 1710
  • Prevalence of arthritis in the United States, 778
  • Prevalence gradient hypothesis, in SLE, African-origin populations, 2091
  • Procalcitonin
    • as a diagnostic test, 567
    • as marker of infection in autoimmune diseases, 566
  • Propionibacterium acnes, in oligoarthritis associated with acne and pustulosis, 1889
  • Prostacyclin, in SSc, 466, 559
  • Prostaglandin E2 (PGE2)
    • calcium-stimulated release, in RA, 246
    • interleukin-1α and tumor necrosis factor α induction of interleukin-11 in RA, 2004
    • in OA, 891
    • in synoviocytes and fibroblasts, 1748
    • Tripterygium wilfordii Hook F effect on production of, 130
  • Proteins
    • cartilage-derived morphogenetic, in articular cartilage and matrix replacement in vitro, 263
    • centrosomal, autoantibodies to, 553
    • Env/Tax, autoantigens in human T cell leukemia virus type I, 101
    • eosinophil cationic protein, in Churg-Strauss syndrome, 445
    • heat shock, 855
    • link, stimulation of proteoglycan biosynthesis in human articular cartilage, 157
    • microsphere encapsulation of, for joint therapy, 2185
    • parathyroid hormone-related protein (PTHrP), articular expression, 2152
    • ribosomal S10, cross-reactivity with monoclonal antibody anti-Sm, 1040
  • Proteoglycans
    • biosynthesis in human articular cartilage, 157
    • cartilage, G1 domain in RA, 1019
    • heparan sulfate, in rheumatoid synovitis, 1365
    • -induced polyarteritis in mice, 1007
    • inhibition of, in cartilage destruction, 274
    • interleukin-1 regulation of matrix metalloproteinase-induced neoepitopes, in antigen-induced arthritis, 647
  • Pseudogout
    • in carpal tunnel syndrome, 182
    • following intraarticular injection of sodium hyaluronate, 939
  • Pseudoobstruction, and upper intestinal manometry in SSc, 1874
  • Psoriatic arthritis (PsA)
    • cyclooxygenase isoforms in, 122
    • prevalence in United States, 778
    • prognostic indicators for mortality in, 1103
  • Pulmonary hypertension, prostacyclin in SSc-associated, 466
  • Purine receptor agonists, in RA, 246
  • Pustulosis, oligoarthritis associated with acne and, 1889
  • Pyrophosphate, inorganic, and parathyroid hormone-related protein, 2152